Wonder Drugs or Not? Why People Stop Taking GLP-1 Weight Loss Medications

Topic of the Month on ModernWeight: Benefits!

Head to the Social Hub to chat about the benefits of GLP-1 medications, including but not limited to weight loss.

AOMs in the News

Staying on GLP-1 Obesity Drugs for Long-Term Success

Link: Verywell Health Article

Adhering to GLP-1 medications is crucial for achieving long-term weight loss. This article highlights patients' challenges in maintaining their treatment regimen and offers strategies to improve adherence and maximize benefits.

Call for National Dialogue on GLP-1 Access

Link: Pharmacy Times Article

A leading physician urges a national conversation on the inequitable access to GLP-1 medications. These life-saving drugs are often out of reach for many, and addressing this issue is critical for ensuring equitable healthcare.

GLP-1s Reduce Cardiovascular Risk Equally

Link: AJMC Article

GLP-1 drugs reduce cardiovascular risks equally in patients with overweight and obesity, regardless of diabetes status. This finding underscores the broad benefits of GLP-1 medications in managing cardiovascular health alongside weight loss.

Potential Eye Disorder Linked to Novo Nordisk’s Obesity Drug

Link: TipRanks Article

Novo Nordisk’s obesity drug has been potentially linked to an eye disorder. This article delves into the emerging concerns and ongoing investigations regarding the safety profile of this widely used medication.

GLP-1 Drugs May Reduce Cancer Risk

Link: Healthline Article

GLP-1 drugs like Ozempic may lower the risk of several types of cancer. This exciting discovery adds another layer of benefits to these medications, highlighting their potential role in cancer prevention as part of a comprehensive weight management plan.

Expert Tweet of the Week

From: @MichaelAlbertMD

"Cost dilemmas around GLP1 are everywhere even in Novo’s home country. If price negotiation is not an option the most effective approach to maximize ROI is restricting prescriptions to providers who will use them best. Many won't like this option."

Related Article: Doctors Must Keep Prescriptions of Ozempic in Check, Danish Regulator Says

---

Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.

Want to receive this newsletter in your inbox weekly? Create a profile!